Wilms tumour protein IVD, antibody

This category includes antibodies designed to detect Wilms tumour protein (WT1) in clinical specimens. These immunoglobulins bind specifically to WT1, a transcription factor associated with certain cancers, and are used in laboratory tests to support diagnosis or monitoring.

Devices in this category are in vitro diagnostic reagents intended for qualitative or quantitative detection of WT1. They are regulated as IVDs and supplied for use in clinical laboratory settings, with their classification depending on the intended use and jurisdiction.